Literature DB >> 14672479

Pregnancy-related mortality among women aged 35 years and older, United States, 1991-1997.

William M Callaghan1, Cynthia J Berg.   

Abstract

OBJECTIVE: To describe pregnancy-related deaths among women 35 years and older and to compare their risk of death to that for 25-29-year-old women.
METHODS: Pregnancy-related deaths in the United States among women 35 years and older from 1991 through 1997 were identified through the Center for Disease Control and Prevention's Pregnancy Mortality Surveillance System. Pregnancy-related mortality ratios (deaths per 100,000 live births) and risk ratios (compared with 25-29-year-old women) for women 35-39 years old or 40 years and older were calculated and stratified by race, obstetric and demographic variables, and cause of death.
RESULTS: There was an excess risk of death for women 35 years and older regardless of parity, time of entry into prenatal care, and level of education. Among white women, the risk ratios for death from hemorrhage, infection, embolisms, hypertensive disorders of pregnancy, cardiomyopathy, cerebrovascular accidents, or other medical conditions ranged from 1.8 to 2.7 for those aged 35-39 years and from 2.5 to 7.9 for those 40 years and older. Among black women the risk ratios for death from these conditions ranged from 2.0 to 4.1 for those aged 35-39 years and from 4.3 to 7.6 for those 40 years and older.
CONCLUSION: Recognition of the risk of death borne by older pregnant women is needed to inform their care before, during, and after pregnancy. Thorough review of all maternal deaths as a core public health function may shed light on the reasons for excess pregnancy-related mortality among older women.

Entities:  

Mesh:

Year:  2003        PMID: 14672479     DOI: 10.1016/s0029-7844(03)00740-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Maternal chronological age, prenatal and perinatal history, social support, and parenting of infants.

Authors:  Marc H Bornstein; Diane L Putnick; Joan T D Suwalsky; Motti Gini
Journal:  Child Dev       Date:  2006 Jul-Aug

2.  Pregnancy-Related Deaths, Florida, 1999-2012: Opportunities to Improve Maternal Outcomes.

Authors:  Leticia E Hernandez; William M Sappenfield; Karen Harris; Deborah Burch; Washington C Hill; Cheryl L Clark; Isaac Delke
Journal:  Matern Child Health J       Date:  2018-02

3.  Contribution of maternal age and pregnancy checkbox on maternal mortality ratios in the United States, 1978-2012.

Authors:  Nicole L Davis; Donna L Hoyert; David A Goodman; Ashley H Hirai; William M Callaghan
Journal:  Am J Obstet Gynecol       Date:  2017-05-05       Impact factor: 8.661

4.  Continued evidence for safety of endoscopic retrograde cholangiopancreatography during pregnancy.

Authors:  Sean Fine; Joshua Beirne; Silvia Delgi-Esposti; Fadlallah Habr
Journal:  World J Gastrointest Endosc       Date:  2014-08-16

5.  Contraceptive methods and use by women aged 35 and over: A qualitative study of perspectives.

Authors:  Emily M Godfrey; Nancy P Chin; Stephen L Fielding; Kevin Fiscella; Ann Dozier
Journal:  BMC Womens Health       Date:  2011-02-16       Impact factor: 2.809

6.  The intergenerational effects on birth weight and its relations to maternal conditions, São Paulo, Brazil.

Authors:  Leide Irislayne Macena da Costa e Silva; Filumena Maria da Silva Gomes; Maria Helena Valente; Ana Maria de Ulhôa Escobar; Alexandra Valéria Maria Brentani; Sandra J F E Grisi
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

7.  Clinical Outcomes in High-Risk Pregnancies Due to Advanced Maternal Age.

Authors:  Rosaly Correa-de-Araujo; Sung Sug Sarah Yoon
Journal:  J Womens Health (Larchmt)       Date:  2020-11-13       Impact factor: 2.681

8.  Popular contraceptive methods in women aged 35 years and older attending health centers of 4 cities in khuzestan province, iran.

Authors:  Sedighe Nouhjah; Elham Amiri; Azim Khodai; Azar Yazdanpanah; Maryam Nadi Baghu
Journal:  Iran Red Crescent Med J       Date:  2013-10-05       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.